Preparation of the AGEs
AGEs were prepared according to following procedure: 0.5 g BSA was added into 10 mM/L phosphate buffered salt of 100 mL (PBS, pH=7.4) and then incubated with 50 mM/L D-glucose in 5% CO 2 at 37 º C for 12 weeks. The free glucose was removed by dialysis overnight in PBS. The final AGEs were stored at -20 º C for further use.
Cell treatment
Cells were pre-treated with RAGE-Ab (5μg/mL), vitamin E (0.1 mM), aminoguanidine (AG, 0.1 mM), curcumin, or demethoxycurcumin (10 -11 -10 -9 M) for 30 min, and then 200 μg/mL
AGEs was added to co-incubate for 48 h. After being incubated, cell supernatant was taken for determination of SOD and MDA; cells were used for ROS and apoptosis assay.
Evaluation on AO/EB apoptosis staining
Acridine orange/ethidium bromide (AO/EB) staining was used to evaluate the attenuation of 
Flow cytometry analysis for apoptosis
Annexin V-FITC/PI flow cytometry analysis was used to quantify the apoptosis. As shown in Fig. 4 , and 10 -9 M decreased significantly apoptosis ratio to 12.43±0.46%, 10.80±0.61%, and 7.67±0.72%, respectively. The results demonstrated that curcumin and demethoxycurcumin had a significant protective activity on AGEs-induced cell apoptosis. RAGE-Ab (5μg/mL)+200 μg/mL AGEs (c); 10 -9 M C+200 μg/mL AGEs (d); 10 -10 M C+200 μg/mL AGEs (e); 10 -11 M C+200 μg/mL AGEs (f); 10 -9 M DC+200 μg/mL AGEs (h); 10 -10 M DC+200 μg/mL AGEs (i); 10 -11 M DC+200 μg/mL AGEs (j). Magnification: 200×. AGEs (d); 10 -10 M C+200 μg/mL AGEs (e); 10 -11 M C+200 μg/mL AGEs (f); 10 -9 M DC+200 μg/mL AGEs (h); 10 -10 M DC+200 μg/mL AGEs (i); 10 -11 M DC+200 μg/mL AGEs (j). 
